254 related articles for article (PubMed ID: 22972196)
1. Models of bone metastasis.
Campbell JP; Merkel AR; Masood-Campbell SK; Elefteriou F; Sterling JA
J Vis Exp; 2012 Sep; (67):e4260. PubMed ID: 22972196
[TBL] [Abstract][Full Text] [Related]
2. Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer.
Xia TS; Wang J; Yin H; Ding Q; Zhang YF; Yang HW; Liu XA; Dong M; Du Q; Ling LJ; Zha XM; Fu W; Wang S
Oncol Rep; 2010 Jul; 24(1):203-11. PubMed ID: 20514463
[TBL] [Abstract][Full Text] [Related]
3. The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs.
Michigami T; Hiraga T; Williams PJ; Niewolna M; Nishimura R; Mundy GR; Yoneda T
Breast Cancer Res Treat; 2002 Oct; 75(3):249-58. PubMed ID: 12353814
[TBL] [Abstract][Full Text] [Related]
4. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
5. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
7. Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation.
Sasaki SI; Zhang D; Iwabuchi S; Tanabe Y; Hashimoto S; Yamauchi A; Hayashi K; Tsuchiya H; Hayakawa Y; Baba T; Mukaida N
Cancer Sci; 2021 Dec; 112(12):4883-4893. PubMed ID: 34632664
[TBL] [Abstract][Full Text] [Related]
8. Enpp1: a potential facilitator of breast cancer bone metastasis.
Lau WM; Doucet M; Stadel R; Huang D; Weber KL; Kominsky SL
PLoS One; 2013; 8(7):e66752. PubMed ID: 23861746
[TBL] [Abstract][Full Text] [Related]
9. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
[TBL] [Abstract][Full Text] [Related]
10. Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.
Elshafae SM; Dirksen WP; Alasonyalilar-Demirer A; Breitbach J; Yuan S; Kantake N; Supsavhad W; Hassan BB; Attia Z; Alstadt LB; Rosol TJ
Prostate; 2020 Jun; 80(9):698-714. PubMed ID: 32348616
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
12. "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".
Marsden CG; Wright MJ; Carrier L; Moroz K; Pochampally R; Rowan BG
BMC Cancer; 2012 Jan; 12():10. PubMed ID: 22233382
[TBL] [Abstract][Full Text] [Related]
13. An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.
Shah M; Huang D; Blick T; Connor A; Reiter LA; Hardink JR; Lynch CC; Waltham M; Thompson EW
PLoS One; 2012; 7(1):e29615. PubMed ID: 22253746
[TBL] [Abstract][Full Text] [Related]
14. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
Lau WM; Weber KL; Doucet M; Chou YT; Brady K; Kowalski J; Tsai HL; Yang J; Kominsky SL
Int J Cancer; 2010 Feb; 126(4):876-84. PubMed ID: 19642106
[TBL] [Abstract][Full Text] [Related]
15. Characterization of brain and bone-metastasizing clones selected from an ethylnitrosourea-induced rat mammary carcinoma.
Hall DG; Stoica G
Clin Exp Metastasis; 1994 Jul; 12(4):283-95. PubMed ID: 8039303
[TBL] [Abstract][Full Text] [Related]
16. Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing.
Chen Y; Rittling SR
Clin Exp Metastasis; 2003; 20(2):111-20. PubMed ID: 12705632
[TBL] [Abstract][Full Text] [Related]
17. Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.
Marsden CG; Wright MJ; Carrier L; Moroz K; Rowan BG
PLoS One; 2012; 7(11):e47587. PubMed ID: 23173031
[TBL] [Abstract][Full Text] [Related]
18. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.
Nickerson NK; Mohammad KS; Gilmore JL; Crismore E; Bruzzaniti A; Guise TA; Foley J
PLoS One; 2012; 7(1):e30255. PubMed ID: 22276166
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice.
Rose DP; Connolly JM; Meschter CL
J Natl Cancer Inst; 1991 Oct; 83(20):1491-5. PubMed ID: 1920496
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell property and gene signature in bone-metastatic Breast Cancer cells.
Luo A; Xu Y; Li S; Bao J; Lü J; Ding N; Zhao Q; Fu Y; Liu F; Cho WC; Wei X; Wang H; Yu Z
Int J Biol Sci; 2020; 16(14):2580-2594. PubMed ID: 32792858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]